Submitted by Anonymous (not verified) on 27 September 2023 - 8:44
Human medicines European public assessment report (EPAR): Harvoni, ledispavir,sofosbuvir, Hepatitis C, Chronic, Date of authorisation: 17/11/2014, Revision: 28, Status: Authorised
Source: